FARALLON CAPITAL MANAGEMENT LLC

Q2 2019 13F Holdings Report, New Holdings, Stock Holdings

Signature - Title
John R. Warren - Managing Member
Location
San Francisco, CA
Holdings as of
June 30, 2019
Value $
$964M
Num holdings
1
Date filed
11/14/2019, 03:24 PM
Description
Request for Confidential Treatment (8/14/2019): Confidential Treatment Expired on 11/14/2019. The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as of the end of the calendar quarter for which the report is filed, and the total market value. The market value column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in accounts.
Previous filing
Q1 2019 - May 15, 2019
Next filing
Q3 2019 - Nov 14, 2019
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

This filing lists securities holdings reported on the form 13F filed on 08-14-2019 pursuant to a request for confidential treatment and for which confidential treatment expired on 11-14-2019.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Michael B. Fisch Managing Member San Francisco, California 11/14/2019

This amendment adds securities holdings to those reported by the reporting manager on its Form 13F-HR filed on August 14, 2019 for the quarter ended June 30, 2019. Such holdings are added pursuant to the expiration of confidential treatment.